Optimize Meds for Peripheral Artery Disease

Debate will brew about how to manage stable peripheral artery disease (PAD)...now that Xarelto (rivaroxaban) is approved for this use.

Think of managing PAD as similar to coronary artery disease.

Plaque buildup puts PAD patients at high risk of complications, such as CV events or limb amputation. And they may develop symptoms...such as claudication or pain that reduces walking distance and quality of life.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote